New Tolracol Offers Effective Coccidiosis Control

7 years ago
2841 views

Posted
2nd May, 2017 11h11

New Tolracol offers effective coccidiosis control

Vets prescribing products to control coccidiosis in sheep, cattle and pigs now have a new product available offering effective, economic control in a single dose.

Tolracol® from Krka is a 50mg/ml suspension of toltrazuril which can be used in all three target species, to prevent coccidiosis infections in youngstock on farms with a history of the disease, explains Krka’s head of sales and marketing, Killian Gaffney.

“Coccidiosis can have a devastating impact on young animals, resulting in ill-thrift, weight loss and potentially death, making its prevention a vital component of herd or flock management.

“Importantly, this is a tri-licence single dose product which requires vet prescription. The involvement of the vet in prescribing coccidiostats is important as their use should be part of a whole management approach to prevention,” adds Mr Gaffney.

Tolracol should be used ahead of the peak infection period on farms with a pre-existing coccidiosis problem, with it recommended for use in neonatal pigs at three to five days old and as soon as required in calves and lambs.

“This product has been proven in trials and offers a cost effective option for farmers, it is also easily administered which farmers will find attractive.  Krka is launching a new farmer campaign to support Tolracol,” says Mr Gaffney.

“With lambing and spring calving now taking place across the country vets are likely to be asked in the coming weeks and months about coccidiosis prevention. Tolracol provides another valuable tool in the armoury when it comes to preventing this nasty condition and should be considered as a first-choice product.”

Krka is launching a marketing campaign to supports vets selling Tolracol and will launch a farmer education campaign shortly.

Piglets and lambs require a dose of 0.4ml/kg bodyweight

Calves require 3ml/kg bodyweight

Tolracol’s innovative pump system makes for easy, accurate dosing

ENDS

Tolracol contains toltrazuril. UK: POM-V. IE: POM.

Further information available in the SPC or from Krka UK Limited, Churchill House, 1 London Road, Slough, SL3 7FJ. Tel +44 (0) 2071 646 156. 

Email [email protected]. Date of preparation April 2017

Use Medicines Responsibly

For further press information, please contact: Killian Gaffney on +44 (0)7572 410 234 or email [email protected]

About Krka:

Krka is among the top 5 generic pharmaceutical companies in the world and has been successfully implementing its strategies and pursuing its mission and vision for more than sixty years.

Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company’s activities are supplemented by health resort and tourist services.

Krka products are sold in over 70 countries. As part of the company’s business strategy it has set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.

Krka develops innovative generic medicines, i.e. generic medicines with value added, which are the products of its own in-house knowledge, and provides products with major advantages for years after market entry. All Krka pharmaceuticals offer high quality, efficacy and safety, and are marketed as own brands.

As a generic producer, Krka is responsible for medicines that can take their place alongside the world’s leading pharmaceutical companies in terms of quality, safety and efficacy. Quality, in the broadest sense of the word, is created, maintained, and the responsibility of all employees. Krka’s systematic approach is intended to ensure it exceeds customer requirements and achieve its set operating objectives.

Krka's strategy for own-brand generic pharmaceutical development is achieved through investment in research and development capacity and Krka's own production and distribution centres around the world.

Krka’s business performance is based on the commitment and the knowledge of its employees. Krka is committed to acquiring, motivating and retaining dedicated and capable staff and building an international corporate culture. Investment in knowledge and the development of all its employees helps them to become among the very best in their own fields of work

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause